Characterization of a novel nuclear Rab protein
新型核 Rab 蛋白的表征
基本信息
- 批准号:7230197
- 负责人:
- 金额:$ 11.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-01 至 2010-03-31
- 项目状态:已结题
- 来源:
- 关键词:AntibodiesApoptosisBreastCancer cell lineCell DeathCell NucleusCell SurvivalCellsCo-ImmunoprecipitationsCoupledCytoplasmic ProteinDataDepthDevelopmentDominant-Negative MutationDown-RegulationEventFamilyFamily memberFibroblastsFreezingFutureGTP BindingGTP-Binding ProteinsGenesGreen Fluorescent ProteinsGrowthHumanImmunoprecipitationLY294002LaboratoriesLocalizedMessenger RNAMolecularMolecular Mechanisms of ActionMusMutagensNamesNormal tissue morphologyNuclearOncogenicPTEN geneParaffin EmbeddingPathway interactionsPhosphatidylinositide 3-Kinase InhibitorPlayProtein FamilyProtein OverexpressionProteinsProteomicsRNA InterferenceReagentResearch PersonnelRoleSignal PathwaySignal TransductionSite-Directed MutagenesisSpecificitySpecimenStressSulindac SulfideSystemThapsigarginTissuesTransmembrane TransportUltraviolet RaysYeastsbasecarcinogenesiscell growthgenetic regulatory proteinhybrid proteininsightintracellular protein transportmRNA Expressionmalignant breast neoplasmmembermetaplastic cell transformationmutantnovelprogramsprotein transportrab GTP-Binding Proteinsresponsetraffickingtumorigenesisyeast two hybrid system
项目摘要
DESCRIPTION (provided by applicant): Rab GTP-binding proteins are members of the Ras supergene family. Rab proteins are generally involved in protein transport/trafficking and determine the specificity of membrane transport steps within cell. We have identified a novel member of the Rab protein family, which we have named Nu-Rab, for its unique nuclear localization. Nu-Rab mRNA is highly expressed in most of cancer cell lines examined, and it is overexpressed in more than 60% of human primary breast cancers when compared to their matching normal tissues. The GFP- and Myc-tagged Nu-Rab mainly localizes to nucleus with some distribution noted in the cytoplasmic subcellular compartment. Immnunochemistry using Nu-Rab antibodies generated in our laboratory also detects that the endogenous Nu-Rab predominantly localizes to nucleus. Nu-Rab expression is down-regulated by apoptosis inducing agents such as ultraviolet radiation (UV), thapsigargin and sulindac sulfide. The PI3-kinase inhibitor LY294002, PI3-K phosphotase PTEN and dominant-negative mutant-Akt also down-regulate Nu-Rab mRNA expression, suggesting that Nu-Rab is a potential downstream target of the PI3-K/Akt signaling pathway. We are now proposing to further investigate the role of Nu-Rab in cell growth and/or survival and to elucidate the molecular basis of its overexpression in human breast cancer. In specific aim 1, we will analyze a larger pool of fresh-frozen and paraffin-embedded tissue specimens to evaluate the expression of Nu-Rab at the mRNA and protein levels. In specific aim 2, we will initiate functional studies to explore the effect of wild type-and GTP-binding mutants of Nu-Rab protein in oncogenic transformation. We will also explore whether Nu-Rab overexpression or deficiency effects apoptosis induced by genotoxic and non-genotoxic agents. Studies in specific aim 3 will be initiated to identify potential Nu-Rab effectors/regulator proteins in order to explore whether Nu-Rab plays a role in nuclear-cytoplasmic protein trafficking and study potential signaling events modulated by Nu-Rab. These are exploratory/developmental studies that, upon completion, will generate sufficient new data and reagents that will form the basis of future in-depth studies investigating the molecular mechanisms (s) of action of this novel GTP-binding protein in breast cancer development and/or progression.
描述(由申请人提供):Rab gtp结合蛋白是Ras超基因家族的成员。Rab蛋白通常参与蛋白质运输和运输,并决定细胞内膜运输步骤的特异性。我们已经确定了Rab蛋白家族的一个新成员,我们将其命名为Nu-Rab,因为它具有独特的核定位。Nu-Rab mRNA在大多数被检测的癌细胞系中高度表达,并且在60%以上的人类原发性乳腺癌中,与匹配的正常组织相比,Nu-Rab mRNA过表达。GFP和myc标记的Nu-Rab主要定位于细胞核,并在细胞质亚细胞室中有一些分布。使用我们实验室产生的Nu-Rab抗体的免疫化学也检测到内源性Nu-Rab主要定位于细胞核。凋亡诱导剂如紫外线辐射(UV)、thapsigargin和sulindac sulfide下调Nu-Rab的表达。pi3激酶抑制剂LY294002、PI3-K磷酸酶PTEN和显性阴性突变体Akt也下调Nu-Rab mRNA表达,表明Nu-Rab是PI3-K/Akt信号通路的潜在下游靶点。我们现在建议进一步研究Nu-Rab在细胞生长和/或存活中的作用,并阐明其在人类乳腺癌中过表达的分子基础。在具体目标1中,我们将分析大量新鲜冷冻和石蜡包埋的组织标本,以评估Nu-Rab在mRNA和蛋白水平上的表达。在具体的目标2中,我们将启动功能研究,探索Nu-Rab蛋白的野生型和gtp结合突变体在致癌转化中的作用。我们还将探讨Nu-Rab过表达或缺乏是否会影响基因毒性和非基因毒性药物诱导的细胞凋亡。在特定的目标3中,研究将开始鉴定潜在的Nu-Rab效应/调节蛋白,以探索Nu-Rab是否在核细胞质蛋白运输中起作用,并研究Nu-Rab调节的潜在信号事件。这些都是探索性/发展性研究,一旦完成,将产生足够的新数据和试剂,为未来深入研究这种新型gtp结合蛋白在乳腺癌发生和/或进展中的作用分子机制奠定基础。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Regulation of p53 oligomerization by Ras superfamily protein RBEL1A.
- DOI:10.18632/genesandcancer.71
- 发表时间:2015-07
- 期刊:
- 影响因子:0
- 作者:Lui K;Sheikh MS;Huang Y
- 通讯作者:Huang Y
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YING HUANG其他文献
YING HUANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YING HUANG', 18)}}的其他基金
Role of a Novel Lysophospholipase in Tumorigenesis
新型溶血磷脂酶在肿瘤发生中的作用
- 批准号:
8209218 - 财政年份:2008
- 资助金额:
$ 11.55万 - 项目类别:
Role of a Novel Lysophospholipase in Tumorigenesis
新型溶血磷脂酶在肿瘤发生中的作用
- 批准号:
7599214 - 财政年份:2008
- 资助金额:
$ 11.55万 - 项目类别:
Role of a Novel Lysophospholipase in Tumorigenesis
新型溶血磷脂酶在肿瘤发生中的作用
- 批准号:
7467584 - 财政年份:2008
- 资助金额:
$ 11.55万 - 项目类别:
Role of a Novel Lysophospholipase in Tumorigenesis
新型溶血磷脂酶在肿瘤发生中的作用
- 批准号:
8018083 - 财政年份:2008
- 资助金额:
$ 11.55万 - 项目类别:
Role of a Novel Lysophospholipase in Tumorigenesis
新型溶血磷脂酶在肿瘤发生中的作用
- 批准号:
7759205 - 财政年份:2008
- 资助金额:
$ 11.55万 - 项目类别:
Characterization of a putative GTP-binding protein as a novel tumor marker.
假定的 GTP 结合蛋白作为新型肿瘤标志物的表征。
- 批准号:
7266108 - 财政年份:2007
- 资助金额:
$ 11.55万 - 项目类别:
Characterization of a putative GTP-binding protein as a novel tumor marker.
假定的 GTP 结合蛋白作为新型肿瘤标志物的表征。
- 批准号:
7446107 - 财政年份:2007
- 资助金额:
$ 11.55万 - 项目类别:
Characterization of a novel nuclear Rab protein
新型核 Rab 蛋白的表征
- 批准号:
7093752 - 财政年份:2006
- 资助金额:
$ 11.55万 - 项目类别:
Characterization of a novel ER membrane protein SPOC
新型 ER 膜蛋白 SPOC 的表征
- 批准号:
6874380 - 财政年份:2004
- 资助金额:
$ 11.55万 - 项目类别:
Characterization of a novel ER membrane protein SPOC
新型 ER 膜蛋白 SPOC 的表征
- 批准号:
6762103 - 财政年份:2004
- 资助金额:
$ 11.55万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 11.55万 - 项目类别:
A reserch of innovative therapies for hormone treatment-resistance Breast Cancer by targeting apoptosis-related molecules
靶向凋亡相关分子的激素治疗耐药性乳腺癌创新疗法研究
- 批准号:
20K17559 - 财政年份:2020
- 资助金额:
$ 11.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Application of estrogen induced apoptosis in endocrine therapy-resistant breast cancer using Eleanor RNAs as an indicator
以Eleanor RNAs为指标的雌激素诱导细胞凋亡在内分泌治疗耐药乳腺癌中的应用
- 批准号:
18K19479 - 财政年份:2018
- 资助金额:
$ 11.55万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Identifying the molecular basis for resistance to apoptosis in breast and pancreatic cancer
确定乳腺癌和胰腺癌抗凋亡的分子基础
- 批准号:
1974897 - 财政年份:2017
- 资助金额:
$ 11.55万 - 项目类别:
Studentship
The mechanical analysis of nucleic acid-induced cancer selective apoptosis for breast cancer therapy
核酸诱导乳腺癌选择性细胞凋亡的力学分析
- 批准号:
15K20834 - 财政年份:2015
- 资助金额:
$ 11.55万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Analysis of cancer stem cell phenotype of apoptosis-resistant breast cancer cells
抗凋亡乳腺癌细胞的癌症干细胞表型分析
- 批准号:
15K08411 - 财政年份:2015
- 资助金额:
$ 11.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene-Targeted Apoptosis as a Treatment for HER2-Positive Breast Cancer
基因靶向细胞凋亡治疗 HER2 阳性乳腺癌
- 批准号:
8877004 - 财政年份:2015
- 资助金额:
$ 11.55万 - 项目类别:
The Role of Rb phosphorylation in proliferation and apoptosis of breast cancer ce
Rb磷酸化在乳腺癌细胞增殖和凋亡中的作用
- 批准号:
8625004 - 财政年份:2014
- 资助金额:
$ 11.55万 - 项目类别:
The Opposing Roles of BAD: Deciphering the Switch Between Proliferation and Apoptosis in Breast Cancer
BAD 的对立角色:破译乳腺癌增殖与凋亡之间的转换
- 批准号:
200337 - 财政年份:2010
- 资助金额:
$ 11.55万 - 项目类别:
Studentship Programs
Apoptosis of Invasive Breast Cancer Cells by Inhibitors of Intracellular uPA
细胞内 uPA 抑制剂导致侵袭性乳腺癌细胞凋亡
- 批准号:
7811764 - 财政年份:2010
- 资助金额:
$ 11.55万 - 项目类别: